当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2013年第14期
编号:13164045
培美曲塞加顺铂治疗晚期非小细胞肺癌的效果(3)
http://www.100md.com 2013年5月15日 赵富丽 郭人花
第1页

    参见附件。

     [9] Zinner RG,Fossella FV,Gladish GW,et al. Phase Ⅱ study of pemetrexed in combination with carboplatin in the firstline treatment of advanced nonsmall cell lung cancer [J]. Cancer,2005,104(11):2449-2456.

    [10] Scagliotti GV,Kortsik C,Dark GG,et al. Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in advanced nonsmall cell lung cancer:a multicenter,randomized,phase Ⅱ trial [J]. Clin Cancer Res,2005,11(2 Pt 1):690-696.

    [11] Ettinger DS,Bepler G,Bueno R,et al. Non-small cell lung cancer clinical practice guidelines in oncology [J]. J Natl Compr Canc Netw,2006,4:548-582.

    [12] Rollins KD,Lindley C. Pemetrexed:amultitargted antifolate [J]. Clin Ther,2005,27(9):1343.

    [13] Pirker R,Minar W. Chemotherapy of advanced non-small cell lung cancer [J]. Front Radiat The Oncol,2012,42:157-163.

    [14] Rollins KD,Lindley C. Pemetrexed:amultitargeted antifolate [J]. Clin Ther,2004,27(9):1343-1382.

    (收稿日期:2013-02-20 本文编辑:张瑜杰)

您现在查看是摘要介绍页,详见PDF附件